Rituximab vs Tirzepatide

## Rituximab vs Tirzepatide: Overview

This comparison examines the pharmacological differences between **Rituximab** and **Tirzepatide**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

**Tirzepatide**: Dual GIP and GLP-1 receptor agonist.

## Pharmacokinetics

**Half-life**: Rituximab — 22 days; Tirzepatide — 5 days.

## Chemical Properties

**Type**: Rituximab — Antibody; Tirzepatide — Protein.